Sign in
4/A

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-17-036202

President and CEO sold 9,930 shares at an average $17.33 ($172,054)

  • President and CEO acquired 9,930 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

McCarthy Sean A. · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2017-09-01 Exercise or conversion : show line 1 in the form +9,930 $0.95 $9,384 14,175 D
2017-09-01 Sale : show line 2 in the form −9,562 $17.32 $165,614 4,613 D
2017-09-01 Sale : show line 3 in the form −368 $17.50 $6,440 4,245 D
Open-market sales · 9,930 sh · avg $17.33 · $172,054

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-09-01 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −9,930 25,043 D
Loading xslF345X03/doc1.xml…